Correction: A CD80-Biased CTLA4-Ig Fusion Protein with Superior In Vivo Efficacy by Simultaneous Engineering of Affinity, Selectivity, Stability, and FcRn Binding

J Immunol. 2017 Sep 1;199(5):1943. doi: 10.4049/jimmunol.1790013.
No abstract available

Publication types

  • Published Erratum